Drugs / BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell)
BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05382871 | May 2022 → Jul 2023 | COVID-19 | China National Biotec Group Company Limited | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05382871 ↗ |
| Modality | Vaccine | “Inactivated COVID-19 vaccine” NCT05382871 ↗ |
| Route | Intramuscular | “intramuscular injection in the deltoid muscle” NCT05382871 ↗ |